Although assessment of tumor characteristics and/or progression patterns are not available in the EHRs, we hypothesized that the association of CaSR SNPs with tumors at secondary sites (secondary malignancies) is indicative of the progression of primary tumors to these sites. This evidence concerns the gene CASR and neoplasm.